Why Moderna Stock Slipped Today

·1 min read
Why Moderna Stock Slipped Today

What happened Shares of Moderna (NASDAQ: MRNA) slipped 3.7% on Monday as of the market close. The decline appeared to be related to a report in The New York Times that said the U.S. Food and Drug Administration (FDA) requested that COVID-19 vaccine makers expand their clinical trials for children between the ages of five to 11 before seeking emergency use authorization (EUA).

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting